Abnormal and uncontrolled growth of cells is called cancer. It is one of the most chronic and fatal disorders that spreads or invades into other parts of the body. Chemotherapy is the most commonly prescribed treatment of cancer. In chemotherapy, cancer is treated by using combination of various anti-cancer agents, also known as chemotherapeutic agents, as a part of the standard regimen. Major drug classes of chemotherapeutic agents include alkylating agents (cisplatins, tetrazines), anti-metabolites (purines, pyrimidines), anti-microtubule agents (taxanes, vinca derivatives), and cytotoxic agents (anthracyclines). Various types of devices are available for administration of chemotherapeutic agents. Choice of chemotherapy devices depends on the type of cancer and type of therapy a patient is prescribed to undergo. Chemotherapeutic agents are administered intravenously. Venous access device is a surgically implanted device that provides long-term access to major veins. Commonly used venous access devices include catheters and implantable ports. Rise in incidence and prevalence of cancer is expected to boost the demand for chemotherapeutics devices, which in turn, is expected to drive the growth of the market during the forecast period.

Report Overview: https://www.transparencymarketresearch.com/chemotherapy-devices-market.html

The global chemotherapy devices market can be segmented on the basis of device type, end-user, and georgraphy. On the basis of device type, the market can be divided into catheters and cannulas. The catheters segment can be further segregated into non-tunnelled catheters, tunnelled central catheters, surgically implantable catheters or ports, and peripherally inserted central catheters (PICC). The cannulas segment can be further segmented into pumps and others. In terms of end-user, the global chemotherapy devices market can be calssified into hospitals, specialty clinics, and home care. The hospitals segment is expected to hold a significant share of the market due to increase in number of hospital visits and hospital stays across the globe. The global chemotherapy devices market is expected to register a significant growth rate during the forecast period due to factors, such as, increase in research & developemt expenditure and high prevalence of cancer across the globe. According to the National Cancer Institute, based in the U.S., around 5.5 million people are affected with cancer in the U.S and the number is expected to reach 20.3 million by 2026. Rapidly growing prevalence of cancer is likely to propel the demand for chemotherapy practices, which in turn, is expected to support the growth of the chemotherapy device market. Other growth drivers of the market are rise in awareness among people, development in medical infrastructure, and technological advancements in the chemotherapy devices field. Major hurdles encountered by the chemotherapy devices market, on the other hand, include discomfort or dislocation of the devices and rise in risk of infection, which are anticipated to limit the market growth during the forecast period.

Based on geography, the global chemotherapy devices market can be classified into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global chemotherapy device market, followed by Europe. Key drivers of the market in these regions are rising incidence of cancer, developed health care infrastructure, and increased government spending. The chemotherapy device market in Asia Pacific is expected to grow at a rapid pace during the forecast period due to large patient base, developing health care infrastructure, and rising government expenditure in the health care industry in the region. Lack of proper treatment, low income level, and poor patient education are likely to hamper the growth of the chemotherapy device market in Middle East & Africa and Latin America in the next few years.

Obtain Report Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=53442

Major players operating in the global chemotherapy devices market include B. Braun, Advanced Chemotherapy Technologies, Fresenius Kabi, Becton, Dickinson, Halyard Health, ICU Medical, Moog Inc., Smiths Group, Baxter International, Terumo Corporation, Micrel Medical, and Zyno Medical.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: [email protected]
Website: https://www.transparencymarketresearch.com/